Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Snell

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Journal of Chromatographic Science|November 1, 1988
Determination of isosorbide dinitrate in pharmaceutical products by HPLCM Carlson, R D Thompson, R P Snell
British Medical Journal|March 24, 1979
Diet, sunlight, and 25-hydroxy vitamin DA P Snell, W J MacLennan, J Hamilton
The Medical Journal of Australia|June 15, 1992
Continuous subcutaneous apomorphine infusion in Parkinson's diseaseD M Simpkin, R Milner, A P Snell
The New Zealand Medical Journal|June 26, 1985
Familial antithrombin III deficiencyJ O'Donnell, A J Day, A P Snell
Age and Ageing|November 1, 1978
Ultra-violet irradiation and 25-hydroxy-vitamin D levels in sick old peopleA P Snell, W J MacLennan, J C Hamilton
Journal of Chromatographic Science|March 1, 1990
Detection and quantitation of ethylene oxide, 2-chloroethanol, and ethylene glycol with capillary gas chromatographyJ W Danielson, R P Snell, G S Oxborrow
British Journal of Clinical Pharmacology|September 19, 2001
Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administrationN Buss, P Snell, J Bock, et al.
The New Zealand Medical Journal|June 22, 1983
Phenytoin-induced hepatotoxicityJ M Egerton-Vernon, M J Fisk, A P Snell
British Journal of Clinical Pharmacology|December 22, 1999
Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studiesK Jorga, B Fotteler, L Banken, et al.
Clinical Pharmacology and Therapeutics|June 29, 2000
Population pharmacokinetics of levodopa in patients with Parkinson's disease treated with tolcaponeK Jorga, L Banken, B Fotteler, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Journal of Chromatographic Science|November 1, 1988
Determination of isosorbide dinitrate in pharmaceutical products by HPLCM Carlson, R D Thompson, R P Snell
British Medical Journal|March 24, 1979
Diet, sunlight, and 25-hydroxy vitamin DA P Snell, W J MacLennan, J Hamilton
The Medical Journal of Australia|June 15, 1992
Continuous subcutaneous apomorphine infusion in Parkinson's diseaseD M Simpkin, R Milner, A P Snell
The New Zealand Medical Journal|June 26, 1985
Familial antithrombin III deficiencyJ O'Donnell, A J Day, A P Snell
Age and Ageing|November 1, 1978
Ultra-violet irradiation and 25-hydroxy-vitamin D levels in sick old peopleA P Snell, W J MacLennan, J C Hamilton
Journal of Chromatographic Science|March 1, 1990
Detection and quantitation of ethylene oxide, 2-chloroethanol, and ethylene glycol with capillary gas chromatographyJ W Danielson, R P Snell, G S Oxborrow
British Journal of Clinical Pharmacology|September 19, 2001
Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administrationN Buss, P Snell, J Bock, et al.
The New Zealand Medical Journal|June 22, 1983
Phenytoin-induced hepatotoxicityJ M Egerton-Vernon, M J Fisk, A P Snell
British Journal of Clinical Pharmacology|December 22, 1999
Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studiesK Jorga, B Fotteler, L Banken, et al.
Clinical Pharmacology and Therapeutics|June 29, 2000
Population pharmacokinetics of levodopa in patients with Parkinson's disease treated with tolcaponeK Jorga, L Banken, B Fotteler, et al.
Pageof 5